Podcasts about therapies

Today we are bringing you a conversation on how topical therapies can effectively manage atopic dermatitis. Brian Keegan, MD, PhD, FAAD, a dermatologist with Princeton Dermatology, spoke with Alexa Hetzel, MS, PA-C, physician assistant with Schweiger Dermatology Group; Vikash D. Oza, MD, director of pediatric dermatology at NYU Langone; and Amy Spizuoco, DO, FAOCD, dermatologist and dermatopathologist at True Dermatology. In addition to discussing the clinical benefits and impact on patient outcomes of using topical therapies for atopic dermatitis, the panelists explored how health economics research informs treatment decisions by demonstrating the cost-effectiveness and accessibility of topical therapies. The panel also analyzed the potential health care cost savings and resource optimization achieved through strategic use of topical treatments and atopic dermatitis management.

Research is more than just finding interesting stats. It's about finding better ways to deliver savings, simplicity, and support. In this episode, you'll hear from managed care pharmacy researchers who are doing just that, delivering data driven insights to drive affordability and access in health care.  Pat Gleason, PharmD, BCPS, FCCP, FAMCP, assistant vice president of health outcomes; Nick Friedlander, PharmD, clinical program pharmacist; and Simone Ndujiuba, PharmD, BCOP, clinical oncology pharmacist senior principal; and host Alex Cook, senior public relations manager, discuss how Prime's research helps address affordability and accessibility issues and guides health care providers and peers toward clarity on treatment for complex health conditions. Research topics covered:Three-Year Real-World Adherence and Persistence to Glucagon-Like Peptide-1 Receptor Agonists Among Commercially Insured Adults with Obesity without Diabetes Trends in Real-World Persistence to Weight Loss Glucagon-Like Peptide-1 Receptor Agonists from 2021 to 2024 Among Commercially Insured Adults without Diabetes — This study earned a platinum award from AMCP.  Impact of a Medical Claims Automated Glucagon Like Peptide-1 Drugs Prior Authorization Program— This study earned a gold award from AMCP.Validation of Long-term Savings from a Pharmacist-to-Prescriber Telephonic Intervention — This study earned a gold award from AMCP. Total Cost of Care and Adverse Effects Assessment of Bispecific T-cell Engagers and Chimeric Antigen Receptor T-cell Therapies for Relapsed Refractory Follicular Lymphoma  -------------------------Content in this podcast is for informational or educational purposes only.The content also does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.

Are you secretly running on anxiety, even as everyone praises your productivity, drive, and ability to “do it all”? I'm joined by an award-winning psychologist, Dr. Lalitaa Suglani, who breaks down the difference between being simply driven and silently battling high-functioning anxiety—a line so thin, most of us don't even realize we've crossed it.We'll dive deep into what high-functioning anxiety really is, how it hides behind ambition, and why so many busy, successful women are silently caught in its grip. Dr. Lalitaa reveals how childhood patterns might still be running the show, why saying “yes” is sometimes a sign you're feeling “not enough,” and how external success can actually keep you stuck in survival mode. You'll find out what high-functioning anxiety really looks like from the inside out, how it might be showing up in your body, and the practical next steps to help you break free from the overwhelming cycle without sacrificing your ambition or success. By the end of the episode, you'll have the tools to start drawing boundaries and understanding your triggers so you can stay ambitious without the constant wave of stress, guilt, or shame. Hit play and let's dive in.4:53 – What High Functioning Anxiety Really Looks Like for High Achievers11:02 – How Childhood Experiences Shape Adult Anxiety 18:58 – How to Spot the Difference Between Being Driven or Overwhelmed and the External Red Flags of High-Functioning Anxiety 24:11 – The First Real Step to Feeling Better (It's NOT Just Slowing Down)28:57 – The Tools and Therapies that Actually Help and How to Find Support32:36 – What Life After Healing From High-Functioning Anxiety Can Look Like Episode Links:Connect with Dr. Lalitaa: Website | InstagramGrab Dr. Lalitaa's book on High-Functioning Anxiety

In this insightful podcast episode, I chat with Dr. Shahrzad Jalai, an accomplished clinical psychologist with a rich background in linguistics and a deep interest in holistic therapy approaches. Our conversation traverses her personal and professional journey, offering profound insights into the nuances of trauma, innovative therapy techniques, and the fascinating convergence of the body and the psyche. What You'll Learn: Integration of Linguistics in Psychology: Discover how Dr. Jalai transitioned from linguistics to psychology and how her background enriches her clinical practice. Understanding Soul Searching: Hear Dr. Jalai's personal story of transformation through therapy and her eventual foray into psychology. Current Trends in Psychological Health: Insights into the growing trend of emotional dysregulation and the quest for safety among clients. Psyche-Body Connection: Explore the role of the nervous system in mental health and Dr. Jalai's holistic approach to therapy. Jungian Psychology & Dreams: Learn about Jung's philosophies, the interplay of dreams and the unconscious, and how they shape therapeutic strategies. Psychoanalytic vs. Cognitive Therapies: A clear distinction between the objective, structured cognitive approaches and the depth-oriented psychoanalytic therapies. Spotlight on Complexes: Uncover the understated influence of complexes from childhood on our adult life, and the therapeutic exploration of these hidden forces. Somatic Approaches to Trauma: Dive into the methodologies like EMDR and Brainspotting used to integrate physiological responses in treating psychological traumas. Key Takeaways: Trauma is not only processed through the mind but is deeply stored within the body, necessitating a holistic treatment approach. Therapies focused on unity and compassion are vital in bridging human chaos and disconnect, offering pathways to greater personal and societal harmony. Exploring personal traumas and histories provides an opportunity not only for healing but also for uncovering the wisdom and strengths gained through adversity. Professionals must navigate transference carefully to maintain personal well-being and effective therapeutic outcomes. Acknowledging and addressing the interconnectedness of body and mind can significantly enhance the efficacy of psychological interventions. Resources For those interested in delving deeper into Dr. Jalai's transformative work, her book "The Fire That Makes Us" weaves personal and clinical insights into a compelling narrative of healing through trauma. Additionally, her upcoming course "Regulate to Rise" offers practical strategies for nervous system regulation, providing tangible tools for those seeking to improve their mental health. Further information, educational materials, and resources from Dr. Jalai can be found on her website and through her social media platforms, aligning the learnings from this podcast into actionable steps for personal growth and healing. https://alignremedy.com/ https://www.instagram.com/alignremedy https://www.youtube.com/@alignremedy Tiktok: @Dr.jalalipsyd LinkedIn: https://www.linkedin.com/in/shahrzad-jalali-psyd-2b547320/ Support the Podcast If you found this conversation enriching and beneficial, subscribe, rate, and review us on your favourite podcast platform. Your support spreads these essential dialogues, offering more individuals the opportunity to embark on their healing journeys. Share this episode with anyone navigating their own struggles—this discussion could be the guiding light they seek in understanding and overcoming personal trauma. 00:23 Transition from Linguistics to Psychology 02:51 Trends in Clinical Psychology 04:06 The Role of the Nervous System in Mental Health 06:50 Jungian Psychology and Dream Analysis 10:29 Cognitive vs. Analytical Psychology 14:14 Childhood Influences on Adult Complexes 19:38 Somatic Approaches to Trauma 22:16 Understanding EMDR and Brainspotting 25:00 Understanding PTSD and EMDR 25:43 Introduction to Brainspotting 27:32 Self-Spotting Techniques 28:35 Breath Work and Emotional Release 31:21 Holotropic Breathing and Trauma 36:10 Personal Journey and Writing 41:57 The Healing Power of Therapy 44:57 Future of Psychology and Personal Growth See omnystudio.com/listener for privacy information.

A Nemours neurologist receives a prestigious grant from the National Institutes of Health.The funding will be used to study brain patterns that could lead to shared therapies for autism, epilepsy and Alzheimer's disease patients.On this edition of Enlighten Me, Delaware Public Media's Joe Irizarry sits down with Nemours Children's Health Chief of Neurology Dr. Rodney Scott to discuss how his work can help patients.

Is there really one “right” therapy?Or are we just drowning in Google searches, hoping to crack the magical code that will lead to our child finally hitting that big milestone like walking, talking, or finally sleeping through the dang night?So many of us special needs moms fall into the trap of thinking there's one golden-ticket treatment out there. That if we research hard enough, fight hard enough, do enough… we'll find the thing that unlocks all the milestones.But that mindset is the fast track to burnout.In this episode, we're talking about how to think about therapies, early interventions, and what actually helps (hint: it's not just one magic answer). 

Ditching the word psychedelic is helping employers embrace therapies that show "groundbreaking results" including faster recovery and more productive employees, explains Sherry Rais, CEO and co-founder of Enthea, in this episode. In addition to health improvements, these therapies can lead to lower healthcare costs and lower disability costs. Hear more about psychedelic-assisted therapies that can be effective with treatment-resistant patients as well as promising research studies underway in this episode of the DMEC podcast.Resources:From Counterculture to Clinical Treatment, article in @Work magazine (open to the public)What Role Should Health Equity Have in Benefit Discussions?How Can Employers Prepare for Psychedelics?Mentioned in this episode:Are Leave Management Specialists Asking the Right Questions?Increase Your Professional Value. Become a Certified Leave Management Specialist Today: https://dmec.org/certification-and-training/clms-certification/DMEC

Did you know that approximately 50% of breast cancer patients who have been exposed to an aromatase inhibitor (AI) over time in the metastatic setting develop an ESR1 mutation? Credit available for this activity expires: 10/17/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003008?ecd=bdc_podcast_libsyn_mscpedu

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor of Urologic Oncology at the University of Utah, and leading urologic oncologists Dr. Mark Tyson from Mayo Clinic Arizona and Dr. Suzanne Merrill from Colorado Urology.---This podcast is supported by:Ferring Pharmaceuticalshttps://www.ferring.com/home-classic/people-and-families/uro-uro-oncology/bladder-cancer/---SYNPOSISThe discussion delves into the newest treatment strategies and FDA-approved therapies for non-muscle invasive bladder cancer with an emphasis on BCG-refractory patients. They highlight their approaches to sequencing therapies, the real-world applicability of these treatments, and the impact of patient factors in clinical decision-making. The panel also explores emerging trials and innovative treatment mechanisms, emphasizing the importance of personalized care in oncology.---TIMESTAMPS00:00 - Introduction05:09 - Challenges and Strategies in Treatment10:55 - Bladder Sparing Therapies21:41 - Practical Tips for Therapy Administration30:39 - Challenges and Considerations in Reinduction37:05 - Clinical Trials and Future Directions44:11 - Counseling Patients on Treatment Options57:36 - Concluding Thoughts and Future Outlook---RESOURCESCORE-008 Clinical Trial https://www.sciencedirect.com/science/article/abs/pii/S1078143924010147Legend Clinical Trial:https://ascopubs.org/doi/10.1200/JCO.2025.43.5_suppl.802CISTO Studyhttps://pubmed.ncbi.nlm.nih.gov/37980511/

Genetic counsellors Matt and Sandra explore Huntington disease, prenatal and lab-based testing ethics, and how lab genetic counsellors act as gatekeepers. They discuss exclusion testing, the challenges of writing clear lab reports, and recent advances in gene therapy. The episode also covers the growing role of AI and automation in genetic labs, the evolving responsibilities of lab GCs, and how testing impacts life choices like career planning and family decisions.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD information, and to apply for credit, please visit us at PeerView.com/CXX865. CME/NCPD credit will be available until September 18, 2026.Preparing Your Practice for Amyloid-Directed Therapies in Alzheimer's Disease: Key Strategies to Enhance Early Diagnosis and Optimize Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant by Eisai Inc.Disclosure information is available at the beginning of the video presentation.

Mental health challenges continue to affect millions worldwide, with anxiety and depression among the most common disorders. Stuart Dods speaks to Lester Kiewit about his personal journey navigating anxiety and his search for alternatives after conventional therapy failed to provide relief. Stuart shares how psychedelic treatment has become the only approach that truly works for him and reflects on his experience with a recent BBC Africa documentary, including how the story was pitched to him versus how it was ultimately presented. His story highlights the growing interest in alternative healing approaches in Cape Town and offers insight into the choices some people make when traditional mental health services are unavailable or insufficient. Good Morning Cape Town with Lester Kiewit is a podcast of the CapeTalk breakfast show. This programme is your authentic Cape Town wake-up call. Good Morning Cape Town with Lester Kiewit is informative, enlightening and accessible. The team’s ability to spot & share relevant and unusual stories make the programme inclusive and thought-provoking. Don’t miss the popular World View feature at 7:45am daily. Listen out for #LesterInYourLounge which is an outside broadcast – from the home of a listener in a different part of Cape Town - on the first Wednesday of every month. This show introduces you to interesting Capetonians as well as their favourite communities, habits, local personalities and neighbourhood news. Thank you for listening to a podcast from Good Morning Cape Town with Lester Kiewit. Listen live on Primedia+ weekdays between 06:00 and 09:00 (SA Time) to Good Morning CapeTalk with Lester Kiewit broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/xGkqLbT or find all the catch-up podcasts here https://buff.ly/f9Eeb7i Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Welcome to The Superhumanize Podcast. I'm your host, Ariane Sommer, and today we're diving into one of the most paradigm-shifting conversations in modern medicine: the metabolic theory of cancer.For decades, we've been told that cancer is primarily a genetic disease, a matter of unlucky mutations that require aggressive pharmaceutical interventions. But what if that's only part of the story? What if cancer is fundamentally a metabolic disease, a disorder of cellular energy production that we can address through diet, lifestyle, and targeted metabolic therapies?This isn't fringe science. And it's giving patients new hope, and new options, beyond the standard cut, poison, and burn model. Today, I'm thrilled to welcome Dr. Donese Worden to the show. Dr. Worden is a board-certified Naturopathic Medical Doctor, researcher, and global health educator who has dedicated her career to bridging conventional and alternative cancer care. She's collaborated with Banner MD Anderson Cancer Center, served as CEO of Care Oncology, and works directly with Dr. Seyfried on metabolic cancer research. She's also the creator of the 7 Pillars of Health framework, a comprehensive approach to resilience that addresses everything from sleep and gut health to spiritual wellbeing.Dr. Worden's motto is 'Educate, Empower, Enlighten,' and that's exactly what we're going to do today. We'll explore the metabolic theory of cancer, discuss both prevention and treatment strategies, and give you a roadmap for building resilience at every level.Episode Highlights00:00 Welcome + why the “metabolic theory of cancer” matters02:00 Genetics vs. metabolism: why only ~5% is strictly genetic (and gene expression is modifiable)03:45 Warburg's mitochondrial lens; PET scans lighting up because cancer voraciously consumes sugar06:45 How we veered away historically; incentives that kept oncology gene-centric09:00 What damages mitochondria today: toxins, antibiotics (without mitigation), chronic stress10:30 Stress as a metabolic driver; why it keeps glucose high even on a “good” diet12:30 Ketogenic therapy for cancer: high fat, lower protein (individualized), carbs mainly from veggies15:00 Measuring correctly: Keto-Mojo, GKI (Glucose-Ketone Index); skip urine strips for accuracy17:00 Fast stress relief protocols: music-guided entrainment, breath work, active meditation, journaling20:15 Somatic breath work in practice; rapid emotional release21:00 Best fats and how Dr. W screens with food-sensitivity testing first23:15 Keto cycles for prevention: 6-week blocks a couple times per year24:15 Exercise as mitochondrial medicine: HIIT + resistance for biogenesis and cancer risk reduction26:00 The KetoPet model: ketogenic diet + HBOT + interval training; lessons for humans28:15 Starting movement in late-stage cases; meeting people exactly where they are30:15 “Press–Pulse” strategy: what stays constant vs. what's pulsed to outsmart tumor adaptation32:00 Repurposed meds (e.g., metformin, doxycycline) and why many oncologists can't step outside SOC33:00 Bridging care: when surgery/chemo/radiation have a role; aiming at cancer stem cells37:15 Hyperbaric oxygen therapy (HBOT): driving O₂ into cells; why it's pulsed and protocol-specific39:30 Outcomes Dr. W sees most consistently: better quality of life, often longer survival41:00 The psychology of prognosis; belief, stress, and manifestation43:00 The “placebo” as your body's own pharmacy (parasympathetic healing state)44:15 Targeting glutamine along with glucose; where evidence stands now (e.g., berberine, exercise, stress)46:45 The Seven Pillars of Health overview (self-audit)48:30 Pillar 1 — Sleep: deep/REM, how you feel on waking49:15 Pillar 2 — Body: strength,...

From CAR-T therapies to viral vectors, cell and gene treatments are redefining the boundaries of pharmacy practice—but with innovation comes complexity. Host Carolyn Liptak welcomes Dr. Mark Wiencek, Principal Microbiologist with the Technical Services Group at Contec, and Dr. Amanda Frick, Senior Clinical Manager of Market Intelligence at Vizient, to break down the challenges of compounding these advanced therapies.   Listen in as they discuss real-world risk assessments, biosafety considerations, and how hospital pharmacies can safely manage these groundbreaking yet high-risk treatments.   Guest speakers:  Mark Wiencek, PhD Principal Microbiologist, Technical Services Group Contec Amanda Frick, PharmD, BCPS Senior Clinical Manager, Market Intelligence Vizient   Host:  Carolyn Liptak, MBA, RPh  Pharmacy Executive Director  Vizient   Show Notes:  [01:02-01:51] Mark shares his background and experience in microbiology [01:52-04:04] Overview of the types of cell and gene therapies (CGT) currently used in clinical practice [04:05-05:14] Which CGT therapies are most applicable to pharmacy compounding and why [05:15-10:29] Things not on the NIOSH list and the risks [10:30-12:03] Evaluating whether viral vectors can penetrate intact skin and the true occupational exposure risks [12:04-13:18] If hazards are not defined by the NIOSH list, how should these CGT hazards be classified [13:19-15:03] Determining the safest environment for compounding CGT therapies [15:04-20:14] Best practices for decontamination, disinfection, and viral vector handling [20:15-20:59] Do you need a dedicated biosafety cabinet for CGT therapies [21:00-22:55] Recommended resources for further learning   Links | Resources:   Blind and colleagues (Nationwide): Click here Wang and colleagues (Stanford): Click here CONTEC HEALTHCARE WEBINAR Using Bugs as Drugs: Compounding Viral Vectors in Cell & Gene Therapy for Hospital Pharmacies, Mark Wiencek, May 13, 2025: Click here Blind, J.E., Ghosh, S., Niese, T.D., Gardner, J.C., Stack-Simone, S., Dean, A. and Washam, M., 2024. A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapies. Antimicrobial Stewardship & Healthcare Epidemiology, 4(1), p.e15. Click here Deramoudt, L., Pinturaud, M., Bouquet, P., Goffard, A., Simon, N. and Odou, P., 2024. Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacy. Occupational and Environmental Medicine, 81(12), pp.615-621. Click here Korte, J., Mienert, J., Hennigs, J.K. and Körbelin, J., 2021. Inactivation of adeno-associated viral vectors by oxidant-based disinfectants. Human Gene Therapy, 32(13-14), pp.771-781. Click here (abstract only; full article available for purchase) Martino, J.G., McConnell, K., Greathouse, L., Rosario, B.D. and Jaskowiak, J.M., 2024. Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center. Journal of Oncology Pharmacy Practice, 30(8), pp.1442-1449. Click here Penzien, C., 2023. Safe handling of BioSafety drugs and live virus vaccines. Pharm Purch Prod, 20(4), p.12. Click here Petrich, J., Marchese, D., Jenkins, C., Storey, M. and Blind, J., 2020. Gene replacement therapy: a primer for the health-system pharmacist. Journal of Pharmacy Practice, 33(6), pp.846-855. Click here Wang, A., Ngo, Z., Yu, S.J. and MacDonald, E.A., 2025. Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting. American Journal of Health-System Pharmacy, p.zxaf026. Click here   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

On this episode of Managed Care Cast, The American Journal of Managed Care® spoke with Gen Li, PhD, CEO and cofounder of Phesi, a clinical data company that provides AI-driven insights to sponsors and providers to optimize clinical trial efficacy. A recent analysis from Phesi found over 100 diseases currently being studied using GLP-1 RA therapies. The rapid growth of GLP-1 RA therapies being used across multiple, overlapping conditions creates an incentive for efficient and easily accessible clinical trial data to aid sponsors and researchers in establishing control cohorts using Phesi's Trial Accelerator platform and digital patient profiles.

Are cell therapies the key to bridging the gap between discovery research and clinical trials? In the inaugural episode of the Bioprocessing Unfiltered podcast, Bo Wiinberg, chief business development officer at Novo Nordisk Foundation Cellerator, sat with Ran Zheng, CEO of Landmark Bio and shared his expert insight on the promise cell therapies hold for diseases with only treatments but no cures. Their conversation covers the challenges of navigating cell therapy programs through pre-clinical and clinical development journeys, how Cellerator is creating innovative spaces in CMC and manufacturing to fulfill critical needs in the translational space, and what a sustainable global cell therapy manufacturing landscape looks in 5-10 years. Links from this episode:  Bioprocessing SummitLandmark BioNovo Nordisk Foundation Cellerator Bioprocessing Unfiltered: Covering both upstream and downstream processing, analytics, AI and digitization, cell and gene therapy and more, Bioprocessing Unfiltered is your insider's pass to the researchers tackling—and solving—the day-to-day challenges in the bioprocessing industry.Evaluating Biopharma boiler: Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today's decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Evaluating Biopharma digital and educational networking events.

Meet Lauren and Alex from Hummingbird Pediatric Therapies, two passionate professionals revolutionizing care for young people with disabilities. Their multidisciplinary approach spans three Illinois locations, offering everything from occupational and physical therapy to innovative programs like hippotherapy. What makes them unique? They're filling critical gaps between pediatric and adult services through their Therapeutic Life Skills program, while their Intensive Therapy approach delivers more progress in three weeks than traditional therapy models achieve in months.The conversation takes a candid turn when discussing healthcare hurdles. "It's very frustrating when you know something's working or that a family could benefit from something," Lauren shares, detailing how insurance limitations often restrict access to life-changing services. These frustrations mirror my own journey after becoming paralyzed in a car accident, when insurance approved just three hours of care daily despite needing round-the-clock assistance. We explore how finding the right support—like my occupational therapist who introduced me to a game-changing mouse stick—can transform lives through what Alex beautifully describes as "inch stones over milestones."Whether you're navigating disability yourself, supporting someone who is, or simply curious about innovative approaches to therapy, this episode offers raw perspectives on overcoming systemic barriers with creativity and determination. Because as I remind listeners: "I'm paralyzed from the neck down breathing through a machine, but that doesn't stop me from following my dreams and doing what I love to do. I don't got any excuse, and neither should you."

Hunter syndrome is caused by the body's inability to produce a critical enzyme needed to break down cellular waste. The condition can cause damage to organs throughout the body as well as to the brain. A new generation of therapies in development, including a gene therapy currently under review by the U.S. Food and Drug Administration, that has the potential to address the neurological symptoms of the disease. Still, patient advocates have been frustrated by regulatory delays and are seeking to push the FDA and Congress to take action. We spoke with Kristin McKay, CEO of the Hunter syndrome patient advocacy organization Project Alive, about the need for new therapies, the importance of early detection, and the patient community's concerns with regulatory delays in approving needed treatments. An editor's note: Since recording this podcast, the FDA granted accelerated approval to Stealth Biotherapeutics' Forzinity for Barth syndrome, which is referenced in the discussion.

Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘the effectiveness and safety of upadacitinib with secukinumab and adalimumab' and ‘the efficacy of long-term treatment with risankizumab across the updated GRAPPA domains and key related conditions of PsA'.

As Gain Therapeutics announces positive Phase 1b results for its lead compound, GT-02287, pharmaphorum looks back to a conversation with the company's CEO Gene Mack earlier in the year, discussing allosteric small molecule therapies in the Parkinson's disease space. Mack discusses the company's progress in this field, and explores where next in terms of the unmet needs of Parkinson's disease and the potential of this specific area of R&D in the future. You can listen to episode 209a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

Beyond the Calcium Score: Longevity & Your Own Stem CellsClick On My Website Below To Schedule A Free 15 Min Zoom Call:www.Over40FitnessHacks.comOver 40 Fitness Hacks SKOOL Group!Get Your Whoop4.0 Here!Dr. Khoshal Latifzai - Rocky Mountain Regenerative Medicinewww.RMRM.comGuest: Dr. Kal Khoshal, MD (Rocky Mountain Regenerative Medicine, Boulder, CO) Focus: Longevity, prevention-first diagnostics, and regenerative therapies (peptides, hormones, PRP, stem cells).Origin story & model: After Dartmouth Med and a Yale EM residency, Dr. Khoshal left the ER due to burnout and the “band-aid” nature of conventional care. He built a cash-pay concierge clinic to spend 60–90 minutes with patients, run deeper diagnostics, and create long-term, prevention-focused plans. He does not bill insurance (patients keep catastrophic coverage), which lets him order better tests and avoid the admin churn.Diagnostics that actually predict risk:Starts from top U.S. mortality drivers (cardiovascular disease, diabetes, cancer, trauma in older adults) and then chooses biomarkers that best reflect true risk, repeating them multiple times per year and explaining results in plain English with written notes.Cancer screening: uses blood tests that detect circulating tumor DNA (ctDNA) as an early, broad screen; positives are followed by imaging (often full-body MRI or targeted MRI/PET).Heart disease: warns that calcium-score CT can miss early non-calcified plaque (common in 40s–60s). Prefers imaging that sees soft plaque before calcification.Whole-body MRI: advocates this for catching issues (like leg artery disease) that localized scans miss—especially relevant to older adults.Therapies & philosophy:Tools include peptides, hormones, PRP, and stem cells, but only after foundations: exercise, nutrition, and social health—there's no shortcut.Stem cells: strongly prefers autologous (your own) cells that are culture-expanded in a sterile lab, stored, and used over time (IV for systemic repair; guided injections for joints/spine).Cautions against routine allogeneic (donor/cord) cells due to immune reactions and potential long-term autoimmunity.Banking earlier is better, but even older adults can benefit; he shared an 80-year-old scoliosis case that avoided major spine surgery after one procedure.In-clinic process: mini-lipo harvest → lab isolation & expansion → cryostorage (annual maintenance fee ~$350).Advises skepticism about overseas clinics and some cord-blood banks with variable quality/control.If you're interested in online personal training or being a guest on my podcast, "Over 40 Fitness Hacks," you can reach me at brad@over40fitnesshacks.com or visit my website at:www.Over40FitnessHacks.comAdditionally, check out my Yelp reviews for my local business, Evolve Gym in Huntington Beach, at https://bit.ly/3GCKRzV

On this episode of the ATS Breathe Easy podcast, host Amy Attaway, MD, of Cleveland Clinic, continues her discussion with asthma expert Njira Lugogo, MD, of University of Michigan. They talk about collaborations in the pulmonary field, the importance of clinical trials, and career advice for those looking to join the field of pulmonology. In case you missed it, check out part one here: https://www.youtube.com/watch?v=4ubMlFuqsVI 

When it comes to her morning routine, Carolyn Creswell describes herself as a bit of a “biohacker”, trying out different types of alternative therapies. But it’s not just in the mornings that the founder of Carman’s Kitchen explores new ways to get the most out of each day; the chief executive is also looking to AI to boost the company's productivity. This week, BOSS editor Sally Patten finds out about the career and lifestyle hacks of this muesli boss. This podcast was sponsored by Aussie Broadband.See omnystudio.com/listener for privacy information.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AQV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until September 28, 2026.Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and METAvivor. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AQV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until September 28, 2026.Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and METAvivor. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AQV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until September 28, 2026.Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and METAvivor. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AQV865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until September 28, 2026.Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and METAvivor. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

In this episode of The Birth Lounge Podcast, HeHe sits down with clinical pharmacist Dr. Michaela Wachal to unpack the controversy surrounding Tylenol (acetaminophen) use in pregnancy and its potential links to autism and other neurodevelopmental concerns. Together, they dive into what the research actually says (and doesn't say), why transparency and informed consent are so important, and how to navigate decisions around medications in pregnancy with confidence. Dr. Wachal also highlights the bigger picture, like how genetics, environmental toxins, and even maternal stress can play a role in outcomes, and why caring for yourself is just as critical as any prescription. This conversation is packed with nuance, evidence, and practical takeaways to help you feel informed, empowered, and ready to advocate for yourself as you make decisions about your pregnancy care. 00:00 Introduction and Media Misrepresentation 01:05 Personal Story and Birth Lounge App 02:16 Empowering Prenatal Conversations 05:26 Emergency Use Authorization Episode 07:34 Interview with Dr. Michaela Wachal 09:14 Medication Safety in Pregnancy 12:37 Pharmaceutical Industry Failures 15:20 Personal Journey and Advocacy 18:55 Questioning Medical Norms 21:15 Tylenol and Toxins 23:34 Aluminum in Vaccines 27:32 The Importance of Transparency 37:05 Advocating for Education and Understanding 37:51 The Power of Asking Questions 40:21 Nesting and Preparing for Baby 43:17 Managing Fevers During Pregnancy 52:01 Environmental Toxins and Health 01:00:41 Therapies and Support for Children on the Spectrum 01:09:27 Final Thoughts and Encouragement   Guest Bio: Michaela Wachal, PharmD, CSP, is a clinical pharmacist, Certified Specialty Pharmacist, and Clinical Accreditation Manager with nearly a decade of experience in specialty pharmacy. She holds a Doctor of Pharmacy degree from the University of Nebraska Medical Center and a Bachelor of Science in Biochemistry from Doane University. Throughout her career, she's specialized in complex conditions including oncology, fertility, endocrinology, immunology, mental health, and inflammatory diseases—always with a passion for improving patient care, optimizing healthcare systems, and empowering women in medicine. Michaela is also a mom of three, including one child with autism, ADHD, and anxiety, which ignited her deep interest in neurodiversity, integrative health, and individualized medicine. After navigating her own family's challenges, she began researching functional and evidence-based approaches to support children and families living with complex needs. Online, Michaela shares insights from scientific studies on autism, ADHD, vaccines, autoimmune conditions, toxins, and more, always with a focus on helping parents make informed, evidence-based choices. Her work blends professional expertise with personal passion, making her a trusted voice in both the pharmacy world and the parenting community.   INSTAGRAM: Connect with HeHe on IG  Connect with Dr. Wachal on IG    BIRTH EDUCATION: Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience!   Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone!   RESEARCH MENTIONED: 2021 there's a call for action published supported by 91 scientists, clinicians and public health professionals across the globe recommended that pregnant women should be cautioned at the beginning of pregnancy to forego APAP unless it is medically indicated and to minimize the exposure by using the lowest effective dose for shortest possible time https://pubmed.ncbi.nlm.nih.gov/34556849/   Boston Birth cohort published in 2020 looked at acetaminophen metabolites in cord blood samples collected at birth and unchanged acetaminophen levels were detected in all cord plasma samples and acetaminophen burden was associated with higher odds of ADHD  and ASD daignosis there was a 2.3 to 3.5 increased risk for ADHD and 1.6 to 4.1 increased risk for ASD https://pubmed.ncbi.nlm.nih.gov/31664451/   Recently in August Harvard did an analysis using the Navigation Guide methodology that supports evidence consistent with an association between acetaminophen exposure during pregnancy and increased incidence of Neurodevelopmental disorders. This included 46 studies with 27 reporting positive associations with the higher quality studies more likely to show positive correlations https://ehjournal.biomedcentral.com/articles/10.1186/s12940-025-01208-0   Nurses Health Study https://pubmed.ncbi.nlm.nih.gov/30923825/ Spanish birth cohort where acetaminophen exposure was associated with more hyperactivity/impulsivity https://pubmed.ncbi.nlm.nih.gov/27353198/   In 2018 there was a review that showed that 9 prospective cohort studies that all suggested an association between prenatal APAP exposure and neurodevelopmental outcomes - ADHD, ASD or lower IQ and longer duration was associated with increased risk https://pubmed.ncbi.nlm.nih.gov/29341895/   2022 a prospective cohort study in Pennsylvania looked at 2,423 moms using data and children who were exposed to APAP during pregnancy scored higher for child behaviors, sleep problems and attention problems  https://pubmed.ncbi.nlm.nih.gov/36170224/ Keywords: Tylenol pregnancy, acetaminophen pregnancy, Tylenol autism risk, pregnancy medication safety, prenatal care, evidence-based pregnancy, maternal health, neurodevelopment, pregnancy decision making, informed consent pregnancy, pregnancy medications, Dr. Michaela Wachal, Birth Lounge podcast, pregnancy self-care, pregnancy toxins

Sickle cell disease was once considered an incurable disease, until recently. A wide variety of gene therapies have now become available, allowing patients with sickle cell disease to now have futures once thought unimaginable. In this podcast episode, we talk through these treatments and get expert advice on what these treatments mean for our future. 

Please visit answersincme.com/VYT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in women's health discusses the management of vasomotor symptoms (VMS) associated with menopause. Upon completion of this activity, participants should be better able to: Identify VMS as a consequence of menopause; Evaluate the efficacy and safety of new and emerging neurokinin (NK)-targeted therapies for VMS; Implement shared decision-making for optimal VMS treatment outcomes

Drs. Hindiyeh and Hutchinson review new FDA-issued safety warnings for Raynaud's phenomenon and hypertension in CGRP-based migraine treatment. They explore the impact of this label update and share practical strategies for patient management.

In this episode of SurgOnc Today, SSO Peritoneal Surface Malignancy Disease Site Working Group members Dr. Alissa Greenbaum and Dr. Omar Llaguna moderate a discussion with Dr. Maheswari Senthil of UC Irvine and Dr. Richard Alexander of the Rutgers Cancer Institute of New Jersey to dive deep into the history of the development of regional therapies such as HIPEC and PIPAC in the United States. The expert discussants answer tough questions regarding the ethical considerations of modern clinical trials and the implementation of experimental therapies into practice.

Simplify pediatric eczema regimens with once-daily, nonsteroidal treatments. See what's making a difference for young patients and families. Credit available for this activity expires: 9/25/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/framing-future-topical-therapies-atopic-dermatitis-2025a1000p2a?ecd=bdc_podcast_libsyn_mscpedu

Nicotine for memory? Methylene blue for mitochondria? Dr. Josh Axe breaks down 10 controversial compounds—what the science says, what's overhyped, and the key safety and legality questions to ask before you even think about trying them. Watch The Dr. Josh Axe Show every Monday & Thursday on YouTube: https://www.youtube.com/@drjoshaxe?sub_confirmation=1 

Our bodies are naturally designed to heal. But interruptions in energy flow or “blockages” can lead to pain, inflammation, and reduced vitality. Brendan Legel, COO of First Alternative Therapies, helps clients live pain-free without drugs. They use advanced tools like Avazzia microcurrent biofeedback, PEMF (Pulsed Electromagnetic Field) therapy, and molecular hydrogen treatments. These therapies communicate […]

In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes Dallas/Fort Worth–based dermatologist Todd Plott, MD, for an in-depth discussion on the first extended-release formulation of minocycline approved for rosacea. The conversation begins with a historical look at tetracyclines, tracing back to tetracycline in 1953, doxycycline in 1968, and minocycline in 1971. While traditionally used as broad-spectrum antibiotics, these agents have shown efficacy in rosacea primarily due to their anti-inflammatory activity rather than antimicrobial effects. They review head-to-head clinical data showing that extended-release minocycline, commercially available as Emrosi, significantly reduced inflammatory lesions and improved Investigator Global Assessment scores in patients with moderate-to-severe rosacea, outperforming both modified-release doxycycline and placebo. The trial population averaged 25 papules per patient, demonstrating the robust improvement required for trial success. A key point of discussion is minocycline's narrow therapeutic window. While higher doses have raised concerns about adverse effects such as hyperpigmentation and lupus-like drug reactions, pharmacokinetic data show that extended-release dosing achieves lower systemic exposure with fewer safety issues compared to immediate-release formulations. Dr Plott contextualizes this by noting that dermatology indications require far lower doses than in infectious disease, which helps explain the rationale for the extended-release formulation in rosacea. Tune in to the full episode to learn more about how extended-release minocycline and anti-inflammatory dosing fit into current rosacea treatment options, what the latest evidence shows about its efficacy and safety, and how clinicians can gain refreshed perspectives on this long-standing therapy.

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered the effectiveness of ixekizumab in real-world patients with axSpA and PsA, and the real‑world comparison of clinical effectiveness of UPA, TNF inhibitors or IL‑17 inhibitors in patients with axSpA after switching from an initial TNF inhibitor.

Why You Should Listen:  In this episode, you will learn about breakthrough therapies for chronic illness recovery including EBOO and TPE. About My Guest: My guest for this episode is Dr. Tami Lyday.  Tami Lyday, DO, MS has been a physician since 2006 and a functional and integrative specialist since 2017.  Prior to that, she spent 11 years as a family practitioner but was never quite satisfied with conventional medical approaches.  Her mother's illness and subsequent side effects of traditional treatments prompted her to learn more about integrative medicine, and she has not looked back.  Dr. Lyday believes functional and integrative medicine is the best way to ensure lasting recovery as it helps patients determine the root of their health issues and does not rely on medications that treat symptoms while ignoring the underlying causes of illness.  She pursued training and certifications in functional and integrative medicine, including specialty training and certifications in the treatment of mold-related illnesses and Lyme disease. At the time of her certification, she was one of only 26 practitioners in the world who were Shoemaker certified in mold treatment protocols.  After 4 years as a functional and integrative medical practitioner, she opened The Lyday Center to provide a dedicated resource for people who are suffering from mystery illnesses and ailments that don't respond to conventional treatment and are seeking natural solutions to their chronic illnesses.  Since that time, she has expanded her specialties to include the treatment of thyroid disorders and overall energy levels.  Her mission is to heal the world one patient at a time. Key Takeaways: How much does environmental toxicity contribute to chronic illness? How is a patient tested for mold illness? What binders are most commonly used for detoxification?  Do natural binders have a place? What is the role of Actinobacteria and endotoxins in CIRS patients? Can a patient have fungal colonization and potentially benefit from antifungals? Does treating mold also treat Lyme and coinfections? How important is working on the limbic system to set the stage for healing? How might EBOO and TPE support those with autoimmunity? Where in a recovery timeline do EBOO and TPE best fit? Does Hashimoto's occur without mold? What is the role of EBOO?  What is the EBOO process? What is done before and after EBOO to support the patient? Can patients have detoxification or Herxheimer reactions after EBOO or TPE? How might EBOO and TPE help those with Long COVID? What types of infections might EBOO support? What is the role of TPE?  What is the TPE process? What types of toxicants and toxins can be filtered out? How is the removed plasma replaced Might beneficial materials be removed with TPE? Can EBOO or TPE help those with neurodegenerative conditions? Connect With My Guest:  TheLydayCenter.com Interview Date: September 5, 2025 Transcript: To review a transcript of this show, visit https://BetterHealthGuy.com/Episode222. Additional Information: To learn more, visit https://BetterHealthGuy.com. Follow Me on Social Media: Facebook - https://facebook.com/betterhealthguy Instagram - https://instagram.com/betterhealthguy X - https://twitter.com/betterhealthguy TikTok - https://tiktok.com/@betterhealthguy Disclaimer:  The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority. 

In this AANEM session, Chilvana Patel, MD moderates a discussion with Pushpa Narayanswami, MD, Nicholas Silvestri, MD, and Kelly Gwathmey, MD on the evolving treatment landscape in myasthenia gravis (MG). The panel reviews the use of targeted therapies in women of childbearing age with myasthenia gravis, alongside guidance for perioperative care before elective surgery. Through illustrative patient cases, the experts provide insight into practical challenges and emerging opportunities in tailoring advanced immunotherapies to individual patient needs.

This is the best! A great conversation with Katie Asmus!Katie Asmus is a Somatic and Nature-Based Psychotherapist. With a Master's degree in Somatic Psychology, over 30 years of leading individuals and group programs out in nature, and a lifetime of apprenticing to ceremony and rites of passage, Katie says the essence of her work is normalizing, celebrating, and bringing compassion to what it means to be human.  For the past 20 years, alongside maintaining a private psychotherapy practice, she has taught graduate students at Naropa University and Prescott College in the areas of Somatic and Nature-based Therapies. In addition, through the Somatic Wilderness Therapy Institute (and in collaboration with other inspiring colleagues), she created and facilitates both online and in-person workshops and trainings in Somatic Trauma work, Ceremony & Rites of Passage facilitation, as well as in a wide variety of wilderness, adventure, and nature-based therapy skills. Having sat with thousands of people from around the world and from all walks of life, Katie is a tender of the thresholds and strongly believes in the necessity of following our deepest longing while simultaneously knowing and feeling our interconnection and belonging to the greater web of life.Relevant LinksSomatic Nature Therapy InstituteMore About KatiePsychology TodayLinkedInKatie on Will White's Stories from the FieldKatie on The Awakened TherapistKatie on Therapy in the Great OutdoorsMore Ways to ConnectSocial Sciences Week Outdoor Therapy Series 2025

Send us an email @ info@parentcoachesunleashed.com SummaryIn this episode of Parent Coaches Unleashed, hosts Jessica Anger and Carrie Wiesenfeld welcome Jane Kaufman, a mother of two young adults, one of whom is neurodivergent. The conversation explores Jane's journey navigating the complexities of raising a child with autism, the importance of community support, and the challenges of finding appropriate therapies and resources. Jane shares personal anecdotes, insights on family dynamics, and advice for parents facing similar challenges. The discussion emphasizes the significance of self-care, humor, and trusting one's instincts in the parenting journey.TakeawaysThe importance of community support for parents of neurodivergent children.Therapies and early intervention can significantly impact a child's development.Family dynamics play a crucial role in supporting neurodivergent individuals.Navigating medical professionals can be challenging; trust your instincts.Self-care is essential for parents managing overwhelming situations.It's okay to feel overwhelmed and seek help from others.Building independence in neurodivergent children is a gradual process.Sibling relationships can be complex but are vital for emotional support.Using humor can help cope with the challenges of parenting.Every child's journey is unique; avoid comparisons with others.titles

We love to hear from our listeners. Send us a message.On episode 111 of Cell & Gene: The Podcast, Host Erin Harris talks to Ernexa Therapeutics' President and CEO, Sanjeev Luther, about how the company is advancing cell therapy innovation for cancer and autoimmune disease through engineered induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs). Luther shares how Ernexa's synthetic, standardized, off-the-shelf iMSCs are designed to overcome historic hurdles in MSC therapy, including variability, scalability, and manufacturing complexity, by leveraging master cell banks, precise gene editing, and novel product engineering. He also shares insights into the process of developing pro- and anti-inflammatory iMSCs for oncology and autoimmunity.Subscribe to the podcast!Apple | Spotify | YouTube Visit my website: Cell & Gene Connect with me on LinkedIn

Join us for an in-depth conversation with Dr. Aahd Kubbara, a practicing pulmonologist, intensivist, and Assistant Professor of Medicine at the University of Minnesota Medical Center. Dr. Kubbara specializes in pulmonary, allergy, critical care, and sleep medicine, with advanced expertise in interstitial lung disease, asthma, and targeted biological therapies. In this episode, we explore the complexities of lung health and the latest strategies for preventing and managing chronic respiratory conditions: ·       How inflammatory lung diseases can cause long-term scarring. ·       The consequences of untreated or poorly managed asthma over time. ·       What pulmonary fibrosis is and the most effective approaches to treatment. ·       The risks of normalizing chronic respiratory symptoms. ·       Seasonal asthma triggers and how to reduce their impact. With years of experience at the Mayo Clinic and University of Nevada, as well as community pulmonary care practice, Dr. Kubbara offers insights into cutting-edge therapies, personalized medicine, and preventive strategies to maintain lung health. Learn more about Dr. Kubbara and his work in pulmonary medicine here! Episode also available on Apple Podcasts: https://apple.co/38oMlMr  Keep up with Dr. Aahd Kubbara socials here: Instagram: https://www.instagram.com/aahd_kubbara/?hl=en  X : https://x.com/aahdkubbara 

Dr. Tony Ebel addresses one of the most common challenges facing families with chronically ill children: healing interventions overload. Many parents are managing multiple therapies, dozens of supplements, and restrictive diets while feeling like nothing works and their child remains stuck or regresses.Dr. Tony reveals the counterintuitive truth that the most advanced healing approach is "less is more." He explains how well-intentioned interventions can overwhelm a child's already stressed nervous system. The solution is a three-phase approach: Phase 1 focuses exclusively on foundational Neurologically-Focused Chiropractic Care, Phase 2 gradually reintroduces therapies, and Phase 3 is where breakthrough healing occurs. The key message: healing comes from proper sequencing and the child's innate ability, not from piling on more interventions.Key Topics & Timestamps([00:00:00]) - The Overload Crisis - How millions of parents are overwhelmed managing multiple interventions without seeing results([00:04:00]) - When Good Interventions Go Bad - Why overwhelmed nervous systems cause children to plateau or regress despite "doing everything right"([00:09:00]) - Less Is More Philosophy - The advanced approach prioritizes foundation and sequencing over doing everything at once([00:11:00]) - The Computer & Circuit Breaker Analogies - Relatable explanations of how nervous system overload works([00:15:00]) - The Energy Theft Hierarchy - Scientific breakdown of how stress systematically affects gut, immune, and motor systems([00:21:00]) - The Three-Phase Action Plan - Foundation first (Phase 1), gradual reintroduction (Phase 2), breakthrough healing (Phase 3)([00:28:00]) - The Patience Factor & Next Steps - Honest discussion about the difficulty of slowing down and practical guidance for getting started-- Follow us on Socials: Instagram: @pxdocs Facebook: Dr. Tony Ebel & The PX Docs Network Youtube: The PX Docs For more information, visit PXDocs.com to read informative articles about the power of Neurologically-Focused Chiropractic Care. Find a PX Doc Office near me: PX DOCS DirectoryTo watch Dr. Tony's 30 min Perfect Storm Webinar: Click HereSubscribe, share, and stay tuned for more incredible episodes unpacking the power of Nervous System focused care for children!